Researchers Mimicked Bacterial Radiation Resistance
A synthetic antioxidant developed in research could one day shield astronauts and disaster survivors from radiation.
Updated on Oct. 8, 2026 in Life Sciences
Live Poll
Should space agencies prioritize developing radioprotective treatments for long-distance space travel?
In research findings updated through October 2026, scientists developed a synthetic antioxidant that replicates the extreme radiation resistance of the bacterium Deinococcus radiodurans. This research offers potential paths for protecting humans from radiation-induced protein damage.
Why it matters
Radiation toxicity remains a primary barrier to long-term space travel and emergency response, as ionizing radiation damages the proteins essential for cell survival. By targeting protein protection rather than DNA repair, this synthetic approach addresses a core mechanism of radiation injury.
The synthetic antioxidant MDP uses a ternary complex of manganese ions, phosphate, and a synthetic peptide to neutralize reactive oxygen species. This mechanism protects proteins from damage more effectively than natural cellular responses, given that the base organism survives 140,000 grays of radiation, which is 28,000 times the lethal human dose.
The players
Northwestern University
An academic institution active in biochemical and materials science research.
Uniformed Services University
A federal health sciences university focused on military medicine and research.
Duke University
A research university where scientists investigate complex biological survival mechanisms.
The details
Radiation damages proteins that regulate cell survival and repair, and this synthetic antioxidant complex acts to neutralize reactive oxygen species—unstable molecules containing oxygen that react with other molecules in a cell—before they can degrade those proteins. Researchers drew on the properties of Deinococcus radiodurans, an extremophile bacterium that also survived pressures of 3 gigapascals in a March 2026 study. This approach leverages multiple components of the organism to extend its unique radiation-resistant biological capabilities to mammalian cells.
Timeline
December 2024: Research into radiation resistance mechanisms was originally reported.
2025: A study was published regarding membrane-bound bacterial packages in mice.
September 2025: Findings were published on the radiation-protective properties of deinoxanthin pigment.
March 2026: A study demonstrated the bacterium could survive pressures of 3 gigapascals.
October 2026: Scientific findings were updated.
The Tech Race
This work aligns with broader efforts to secure human health against deep-space radiation, where levels are 700 times higher than on Earth. It advances beyond traditional DNA-repair studies by targeting protein integrity, providing a potential pharmaceutical alternative to heavy radiation shielding.
This technology remains in the research phase and is not yet available for human use. Future clinical applications could lead to radioprotective pills for astronauts or individuals exposed to nuclear accidents, though the timeline for development remains unannounced.
The takeaway
The research highlights that protecting cellular proteins is as critical as DNA repair when mitigating radiation damage. Readers should track upcoming clinical data on manganese-based synthetic antioxidants to see if these survival rates in mouse models translate to human safety benchmarks.
Further reading
Explore more developments in human health research in our Life Sciences section.
Source note: This article includes information reported by ZME Science.
Live Poll
Should space agencies prioritize developing radioprotective treatments for long-distance space travel?
